Literature DB >> 3534754

[Klebsiella oxytoca beta-lactamases: study of their action on 3d-generation cephalosporins].

R Labia, A Morand, M Guionie, M Heitz, J S Pitton.   

Abstract

Indole-positive Klebsiella pneumoniae or K. oxytoca are usually resistant to penicillins as a result of the production of a chromosomally-mediated beta-lactamase with a low level of synthesis (specific activity approximately 50 to 100 mU/mg). Although most strains are susceptible to the majority of cephalosporins, some strains exhibit resistance to cephalosporins including third-generation drugs. These resistant strains produce a chromosomally-mediated beta-lactamase with a high level of synthesis (specific activity approximately 5,000 mU/mg or higher). Four beta-lactamases have been identified on the basis of their isoelectric points: pI = 5.5, 5.7, 6.0 and 6.3; nevertheless they have similar kinetic constants, and are inhibited by clavulanic acid. These enzymes hydrolyze most third-generation cephalosporins, in the following order of decreasing velocities: cefoperazone, ceftriaxone, cefotaxime, cefodizime, cefpirome; ceftazidime, and cefoxitin, cefotetan, latamoxef, cephamycins which are totally resistant to these enzymes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534754

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  10 in total

1.  Genetic characterization of resistance to extended-spectrum beta-lactams in Klebsiella oxytoca isolates recovered from patients with septicemia at hospitals in the Stockholm area.

Authors:  S W Wu; K Dornbusch; G Kronvall
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Variability of chromosomally encoded beta-lactamases from Klebsiella oxytoca.

Authors:  B Fournier; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.

Authors:  H C Neu; A Novelli; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

4.  Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.

Authors:  A Petit; D L Sirot; C M Chanal; J L Sirot; R Labia; G Gerbaud; R A Cluzel
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

5.  Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca.

Authors:  B Fournier; C Y Lu; P H Lagrange; R Krishnamoorthy; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

6.  Inhibitor-resistant OXY-2-derived beta-lactamase produced by Klebsiella oxytoca.

Authors:  D Sirot; R Labia; P Pouedras; C Chanal-Claris; C Cerceau; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins.

Authors:  Y Matsumoto; F Ikeda; T Kamimura; Y Yokota; Y Mine
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

8.  Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca.

Authors:  B Fournier; A Gravel; D C Hooper; P H Roy
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

9.  Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics.

Authors:  Y Arakawa; M Ohta; N Kido; M Mori; H Ito; T Komatsu; Y Fujii; N Kato
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

10.  In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.

Authors:  J R Edwards; P J Turner; C Wannop; E S Withnell; A J Grindey; K Nairn
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.